Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
09/07/2012 | WO2012118750A2 Biological markers and methods for predicting response to b-cell antagonists |
09/07/2012 | WO2012118745A1 Assay systems for detection of aneuploidy and sex determination |
09/07/2012 | WO2012118622A1 Diagnostic and therapeutic uses for b cell maturation antigen |
09/07/2012 | WO2012118539A2 Automated particulate concentration system |
09/07/2012 | WO2012118088A1 Method for detecting recurrent prostate cancer |
09/07/2012 | WO2012118017A1 Method for quantifying cholesterol in high-density lipoprotein 2, and reagent kit for the method |
09/07/2012 | WO2012117431A1 Method and reagent kit for the identification of biological fluids in a sample |
09/07/2012 | WO2012117424A1 Brip1 variants associated with risk for cancer |
09/07/2012 | WO2012117367A1 Probe and primer sequences for detection of hepatitis b virus by real-time pcr, pcr reaction mixture and kits thereof. |
09/07/2012 | WO2012117296A1 Method for testing for arrhythmia based on single nucleotide polymorphism in 1q24 region, neurl gene, or cux2 gene |
09/07/2012 | WO2012117267A1 Use of the olfactomedin-4 protein (olfm4) in colorectal cancer diagnosis |
09/07/2012 | WO2012117240A1 Genetic association between rheumatoid arthritis and polymorphisms in the sstr2 gene |
09/07/2012 | WO2012117141A1 METHOD FOR DNA AMPLIFICATION BASED ON THE ORIGINS OF REPLICATION OF THE BACTERIOPHAGE φ29 AND ASSOCIATED NUCLEOTIDE SEQUENCES |
09/07/2012 | WO2012116949A1 Application of quantum dots for nuclear staining |
09/07/2012 | WO2012116780A1 Method for producing a test element for studying a body fluid sample, and test element |
09/07/2012 | WO2012116661A1 Dna tag and use thereof |
09/07/2012 | WO2012116658A2 Method and device for assembling genome sequence |
09/07/2012 | WO2012116578A1 Method for detecting pyrazinamide resistance of mycobacterium tuberculosis |
09/07/2012 | WO2012116432A1 Treatment of cancer with dopamine receptor antagonists |
09/07/2012 | WO2012116386A1 Biosensor array formed by junctions of functionalized electrodes |
09/07/2012 | WO2012116385A1 Biosensor array formed by junctions of functionalized electrodes |
09/07/2012 | WO2012095748A3 Single tube quantitative polymerase chain reaction (pcr) |
09/07/2012 | WO2012092336A3 Molecular profiling for cancer |
09/07/2012 | WO2012091832A3 Modulation of dynein in skin |
09/07/2012 | WO2012079030A3 Bioconjugation using bifunctional linkers |
09/07/2012 | WO2012079003A9 Biomarkers for Tuberculosis and HIV/AIDS |
09/07/2012 | WO2012078648A3 Novel method of cancer diagnosis and prognosis and prediction of response to therapy |
09/07/2012 | WO2012072683A3 Diagnosis of asymptomatic left ventricular systolic dysfunction |
09/07/2012 | WO2012068562A3 Compositions and methods for detection and treatment of b-raf inhibitor-resistant melanomas |
09/07/2012 | WO2012067460A3 Method for screening for materials for promoting the differentiation of skin cells |
09/07/2012 | WO2012060635A3 Polynucleotide for diagnosing sensitivity to stomach cancer |
09/07/2012 | WO2012059839A3 In vitro diagnostic testing including automated brokering of royalty payments for proprietary tests |
09/07/2012 | WO2012057567A3 Kit for screening for skin-activating substances and comprising the klotho gene, and method for screening for skin-activating substances using same |
09/07/2012 | WO2012042374A3 Method of determining number or concentration of molecules |
09/07/2012 | DE202010017796U1 Substanz zur gerichtsverwertbaren Markierung Substance to be used in court marking |
09/07/2012 | CA2828972A1 Interrogatory cell-based assays and uses thereof |
09/07/2012 | CA2828878A1 Predicting gastroenteropancreatic neuroendocrine neoplasms (gep-nens) |
09/07/2012 | CA2828541A1 Sporulation-deficient b. texasporus cells and methods for efficient and cost-effective inactivation and use thereof |
09/07/2012 | CA2828535A1 Kit and method for sequencing a target dna in a mixed population |
09/07/2012 | CA2827859A1 Biological markers and methods for predicting response to b-cell antagonists |
09/07/2012 | CA2827533A1 Enhanced biodistribution of oligomers |
09/07/2012 | CA2824355A1 Application of quantum dots for nuclear staining |
09/06/2012 | US20120227134 Plants with Increased Yield |
09/06/2012 | US20120227131 Transgenic plants with enhanced agronomic traits |
09/06/2012 | US20120227123 Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline and oxidative conditions |
09/06/2012 | US20120227120 Hydrolases, nucleic acids encoding them and methods for making and using them |
09/06/2012 | US20120225928 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
09/06/2012 | US20120225870 Methods for treating cancer resistant to erbb therapeutics |
09/06/2012 | US20120225798 Method for non-invasive prenatal diagnosis |
09/06/2012 | US20120225793 Methods for identifying, diagnosing, and predicting survival of lymphomas |
09/06/2012 | US20120225792 Gene Expression Biomarkers in PAP Test Material for Assessing HPV Presence and Persistence |
09/06/2012 | US20120225790 Vitro method for the prognosis or prediction of the response in patients with rheumatoid arthritis treated with agents that recognize the cd20 membrane receptor in b lymphocytes |
09/06/2012 | US20120225786 Risk variants for cancer |
09/06/2012 | US20120225477 Viral and viral associated mirnas and uses thereof |
09/06/2012 | US20120225448 Substrate with Photo-Controllable Cell Adhesion Property, Method for Analyzing and Fractionating Cells, and Device for Analysis and Fractionation of Cells |
09/06/2012 | US20120225447 Compositions and methods for quantitatively monitoring lipids |
09/06/2012 | US20120225445 Sebocytes, sebocyte cell lines and applications thereof |
09/06/2012 | US20120225437 Methods for identifying inhibitors of mannan-binding lectin associated serine protease (masp) proteins and uses thereof |
09/06/2012 | US20120225434 Screening method for selected amino lipid-containing compositions |
09/06/2012 | US20120225433 Gene Expression Markers for Breast Cancer Prognosis |
09/06/2012 | US20120225432 Method and Kit for the Prognosis of Mantle Cell Lymphoma |
09/06/2012 | US20120225431 Methods of synthesizing and labeling nucleic acid molecules |
09/06/2012 | US20120225429 Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria |
09/06/2012 | US20120225428 Type of universal probe for the detection of genomic variants |
09/06/2012 | US20120225427 sPLA2 IIA Polymorphism Analysis for the Diagnosis/Prognosis of a Cardiovascular Disease/Event |
09/06/2012 | US20120225426 Baalc expression as a diagnostic marker for acute leukemia |
09/06/2012 | US20120225425 Cathepsin E as a Marker of Colon Cancer |
09/06/2012 | US20120225423 Pathogen detection biosensor |
09/06/2012 | US20120225421 Kit and method for sequencing a target dna in a mixed population |
09/06/2012 | US20120225417 Methods, Compositions and Kits for the Evaluation and Preservation of Sperm |
09/06/2012 | US20120225093 Abrogating HIV-1 Infection via Drug-Induced Reactivation of Apoptosis |
09/06/2012 | US20120225084 Klf family members regulate intrinsic axon regeneration ability |
09/06/2012 | US20120225082 ADAM12 Inhibitors and Their Use Against Inflammation-Induced Fibrosis |
09/06/2012 | US20120225078 Immune system modulating composition |
09/06/2012 | US20120225077 Novel molecules of the card-related protein family and uses thereof |
09/06/2012 | US20120225076 Fra-1 target genes as drug targets for treating cancer |
09/06/2012 | US20120225073 Isolation and Use of Melanoma Cancer Stem Cells |
09/06/2012 | US20120225063 Treatment response to anti-angiogenic therapies |
09/06/2012 | US20120225021 Stable colloidal gold nanoparticles with controllable surface modification and functionalization |
09/06/2012 | US20120223260 Method and a system for determination of particles in a liquid sample |
09/05/2012 | EP2495563A1 Diagnostic agent for infectious diseases |
09/05/2012 | EP2495338A1 Use of phenanthridium derivatives for distinguishing between intact and membrane-compromised cells using molecular nucleic acid-based techniques |
09/05/2012 | EP2495337A1 High throughput genome sequencing on DNA arrays |
09/05/2012 | EP2495336A1 A new type of universal probes for the detection of genomic variants |
09/05/2012 | EP2495335A1 Probe for detecting polymorphism in egfr genes, and usage therefor |
09/05/2012 | EP2495334A1 Method for detection of target nucleic acid |
09/05/2012 | EP2495333A1 Method for producing a test element for investigating a bodily fluid sample and test element |
09/05/2012 | EP2495332A1 METHOD FOR MEASURING CHOLESTEROL IN ApoE-CONTAINING HDL |
09/05/2012 | EP2495331A1 Testing method for drug sensitivity of mycobacterium tuberculosis, application of indicator and solid medium |
09/05/2012 | EP2495324A2 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
09/05/2012 | EP2495322A1 Pro-clotting enzyme, and method for detection of (1 --> 3) -ß-D-glucan using the same |
09/05/2012 | EP2495321A1 Pro-clotting enzyme, and method for detection of endotoxin using the same |
09/05/2012 | EP2495318A1 Probe for detecting mpl gene polymorphism and use of the same |
09/05/2012 | EP2494987A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
09/05/2012 | EP2494986A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
09/05/2012 | EP2494865A2 Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using same |
09/05/2012 | EP2494363A1 Method of predicting risk of preterm birth |
09/05/2012 | EP2494360A2 Diagnostic methods for determining prognosis of non-small cell lung cancer |
09/05/2012 | EP2494353A2 Microvessels, microparticles, and methods of manufacturing and using the same |
09/05/2012 | EP2494080A1 Method for screening nucleic acid ligand |